Show simple item record

A First-in-Human Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Novel Anti-Interleukin 1 Biologic Agent, Rph-104, in Healthy Subjects

dc.contributor.authorGül, Ahmet
dc.contributor.authorGÜRGÜN, CEMİL
dc.contributor.authorTurk, Ugur Onsel
dc.contributor.authorSenturk, Recep Selim
dc.contributor.authorUlker, Sibel
dc.contributor.authorAltinel, Serdar
dc.contributor.authorOzen, Sebnem
dc.contributor.authorSamsonov, Mikhail
dc.contributor.authorLavrovsky, Yan
dc.date.accessioned2021-03-05T20:39:51Z
dc.date.available2021-03-05T20:39:51Z
dc.identifier.citationGül A., Ulker S., Senturk R. S. , Turk U. O. , GÜRGÜN C., Lavrovsky Y., Samsonov M., Ozen S., Altinel S., "A First-in-Human Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Novel Anti-Interleukin 1 Biologic Agent, Rph-104, in Healthy Subjects", ARTHRITIS & RHEUMATOLOGY, cilt.69, 2017
dc.identifier.issn2326-5191
dc.identifier.otherav_d54110df-a278-487b-b791-c612ecc731b2
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/140719
dc.language.isoeng
dc.subjectİç Hastalıkları
dc.subjectROMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectDahili Tıp Bilimleri
dc.subjectİmmünoloji ve Romatoloji
dc.titleA First-in-Human Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Novel Anti-Interleukin 1 Biologic Agent, Rph-104, in Healthy Subjects
dc.typeMakale
dc.relation.journalARTHRITIS & RHEUMATOLOGY
dc.contributor.departmentİstanbul Teknik Üniversitesi , Fen-Edebiyat ,
dc.identifier.volume69
dc.contributor.firstauthorID246465


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record